Clinical Trial Update: SUBLIVAC FIX Mite Mixture Dose Tolerability Study [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 dose-tolerability study of SUBLIVAC FIX Mite Mixture for house dust mite allergy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• House Dust Mite Allergy

Drugs mentioned

• SUBLIVAC FIX Mite Mixture

Snippet

Sponsor: HAL Allergy | Conditions: House Dust Mite Allergy | Phase 1, Phase 2 | Status: COMPLETED